Carbon nanomaterials sensitize prostate cancer cells to docetaxel and mitomycin C via induction of apoptosis and inhibition of proliferation

• Kati Erdmann,
• Jessica Ringel,
• Silke Hampel,
• Manfred P. Wirth and
• Susanne Fuessel

Beilstein J. Nanotechnol. 2017, 8, 1307–1317, doi:10.3762/bjnano.8.132

• various therapeutic drugs and to be internalized by cells. Furthermore, the functionalization with targeting ligands against cancer cell-specific molecules such as antibodies, peptides or aptamers represents another advantage of carbon nanomaterials [9][10][11][12]. We and others have previously shown